Cronos Group Inc.
CRON.TOTSXHealthcare● Active
$3.90
+$0.05(+1.30%)
Market Cap$1.5B
P/E Ratio—
52W High$4.66
52W Low$2.54
Cronos Group Inc. (CRON.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CRON.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
$0.06
Est. $0.01 · +700.6%
Revenue
$0.06B
Est. $0.06B · +7.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
CRON.TO reports quarterly as a TSX-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.01 | — | — | — | $0.06B | — |
| ▲ Q2 FY2026 | May 11, 2026 | $0.01 | $0.06 | +700.6% | $0.06B | $0.06B | +7.1% |
| ▼ Q1 FY2026 | Feb 26, 2026 | $0.02 | -$0.01 | -128.8% | $0.06B | $0.05B | +15.0% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.03 | $0.09 | +237.3% | $0.05B | $0.05B | -6.1% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.14 | -$0.10 | +24.3% | $0.03B | $0.05B | -34.8% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.01 | $0.02 | +38.7% | $0.03B | $0.04B | -26.8% |
| ▲ Q1 FY2025 | Feb 26, 2025 | -$0.01 | $0.11 | +1200.0% | $0.03B | $0.05B | -37.7% |
| ▲ Q4 FY2024 | Nov 12, 2024 | $0.01 | $0.02 | +300.0% | $0.03B | $0.05B | -29.6% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
$0.06
EPS Est.
$0.01
EPS Surpr.
+700.6%
Revenue
$0.06B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.01
EPS Est.
$0.02
EPS Surpr.
-128.8%
Revenue
$0.06B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.09
EPS Est.
$0.03
EPS Surpr.
+237.3%
Revenue
$0.05B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.10
EPS Est.
-$0.14
EPS Surpr.
+24.3%
Revenue
$0.03B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.02
EPS Est.
$0.01
EPS Surpr.
+38.7%
Revenue
$0.03B
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
$0.11
EPS Est.
-$0.01
EPS Surpr.
+1200.0%
Revenue
$0.03B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
$0.02
EPS Est.
$0.01
EPS Surpr.
+300.0%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2026 | $0.00 | $0.00 | $0.01 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.0B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +700.6% | $3.47 | $3.75 | +8.07% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -128.8% | $3.80 | $3.67 | -3.42% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +237.3% | $3.47 | $3.47 | +0.00% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +24.3% | $2.88 | $3.11 | +7.99% |
| ▲ Q2 FY2025 | May 7, 2025 | +38.7% | $2.52 | $2.56 | +1.59% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +1200.0% | $2.69 | $2.65 | -1.49% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +300.0% | $2.71 | $3.15 | +16.24% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -700.0% | $3.06 | $3.16 | +3.27% |
Q2 FY2026+8.07%
Report Date
May 11, 2026
EPS Beat/Miss
+700.6%
Price Before
$3.47
Price After
$3.75
Q1 FY2026-3.42%
Report Date
Feb 26, 2026
EPS Beat/Miss
-128.8%
Price Before
$3.80
Price After
$3.67
Q4 FY2025+0.00%
Report Date
Nov 6, 2025
EPS Beat/Miss
+237.3%
Price Before
$3.47
Price After
$3.47
Q3 FY2025+7.99%
Report Date
Aug 7, 2025
EPS Beat/Miss
+24.3%
Price Before
$2.88
Price After
$3.11
Q2 FY2025+1.59%
Report Date
May 7, 2025
EPS Beat/Miss
+38.7%
Price Before
$2.52
Price After
$2.56
Q1 FY2025-1.49%
Report Date
Feb 26, 2025
EPS Beat/Miss
+1200.0%
Price Before
$2.69
Price After
$2.65
Q4 FY2024+16.24%
Report Date
Nov 12, 2024
EPS Beat/Miss
+300.0%
Price Before
$2.71
Price After
$3.15
Q3 FY2024+3.27%
Report Date
Aug 8, 2024
EPS Beat/Miss
-700.0%
Price Before
$3.06
Price After
$3.16
Avg Beat Reaction+5.40%
Avg Miss Reaction-0.07%
Beat Rate6 / 8 quarters
Largest Move+16.24% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CRON.TO ends December
Cronos Group Inc. (CRON.TO) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $0.06 — beating the analyst consensus of $0.01 by +700.6%. The next CRON.TO earnings date is expected around September 1, 2026.
Each quarter, investors track CRON.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CRON.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CRON.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CRON.TO earnings · 5 questionsCronos Group Inc.'s next earnings report is expected around September 1, 2026. CRON.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CRON.TO historically reports after market close (AMC).
CRON.TO earnings datewhen is CRON.TO earningsCRON.TO next earnings datewhen does CRON.TO report earningsCRON.TO earnings calendar
▸ Source: FMP · Cronos Group Inc. SEC filings · US GAAP · Cronos Group Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026